Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
48
HBIO Quote, Financials, Valuation and Earnings
Last price:
$0.73
Seasonality move
:
0.41%
Day range:
$0.72 - $0.75
52-week range:
$0.28 - $2.28
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.37x
P/B ratio:
2.30x
Volume:
237.2K
Avg. volume:
935.1K
1-year change:
-65.13%
Market cap:
$32.3M
Revenue:
$94.1M
EPS (TTM):
-$1.22
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $102.1M | $118.9M | $113.3M | $112.3M | $94.1M | |
| Revenue Growth (YoY) | -12.12% | 16.46% | -4.68% | -0.96% | -16.14% | |
| Cost of Revenues | $44.1M | $57.1M | $57.2M | $51.4M | $44.6M | |
| Gross Profit | $58M | $61.8M | $56.2M | $60.9M | $49.6M | |
| Gross Profit Margin | 56.85% | 51.99% | 49.56% | 54.22% | 52.64% | |
| R&D Expenses | $8.7M | $10.8M | $12.3M | $11.8M | $10.4M | |
| Selling, General & Admin | $43.4M | $48.9M | $49.5M | $46.9M | $43.7M | |
| Other Inc / (Exp) | -$2.7M | -$666K | $535K | -$859K | -$2.2M | |
| Operating Expenses | $57.8M | $58.5M | $60.9M | $58.6M | $54.1M | |
| Operating Income | $221K | $3.3M | -$4.8M | $2.3M | -$4.6M | |
| Net Interest Expenses | $4.8M | $1.5M | $2.5M | $3.6M | $3.2M | |
| EBT. Incl. Unusual Items | -$7.3M | -$140K | -$9.2M | -$2.6M | -$11.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $518K | $148K | $337K | $859K | $740K | |
| Net Income to Company | -$7.8M | -$288K | -$9.5M | -$3.4M | -$12.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$7.8M | -$288K | -$9.5M | -$3.4M | -$12.4M | |
| Basic EPS (Cont. Ops) | -$0.20 | -$0.01 | -$0.23 | -$0.08 | -$0.28 | |
| Diluted EPS (Cont. Ops) | -$0.20 | -$0.01 | -$0.23 | -$0.08 | -$0.28 | |
| Weighted Average Basic Share | $38.6M | $40.3M | $41.4M | $42.4M | $43.5M | |
| Weighted Average Diluted Share | $38.6M | $40.3M | $41.4M | $42.4M | $43.5M | |
| EBITDA | $5.2M | $11M | $2.8M | $9.3M | $2.4M | |
| EBIT | -$2.5M | $3.3M | -$4.8M | $2.3M | -$4.6M | |
| Revenue (Reported) | $102.1M | $118.9M | $113.3M | $112.3M | $94.1M | |
| Operating Income (Reported) | $221K | $3.3M | -$4.8M | $2.3M | -$4.6M | |
| Operating Income (Adjusted) | -$2.5M | $3.3M | -$4.8M | $2.3M | -$4.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $29.7M | $26.9M | $25.4M | $22M | $20.6M | |
| Revenue Growth (YoY) | 23.41% | -9.24% | -5.79% | -13.38% | -6.28% | |
| Cost of Revenues | $14.8M | $15M | $12M | $10.5M | $9.4M | |
| Gross Profit | $14.8M | $11.9M | $13.4M | $11.4M | $11.2M | |
| Gross Profit Margin | 50.06% | 44.28% | 52.7% | 52.03% | 54.23% | |
| R&D Expenses | $2.7M | $2.8M | $2.8M | $2.6M | $2.1M | |
| Selling, General & Admin | $11.6M | $12.1M | $11.5M | $10.6M | $8.8M | |
| Other Inc / (Exp) | -$130K | $365K | $1.3M | -$1.9M | -- | |
| Operating Expenses | $14.2M | $14.3M | $14.3M | $13.1M | $10.9M | |
| Operating Income | $648K | -$2.4M | -$933K | -$1.7M | $245K | |
| Net Interest Expenses | $373K | $749K | $882K | $856K | $966K | |
| EBT. Incl. Unusual Items | $45K | -$4.7M | -$562K | -$4.5M | -$1.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $215K | -$1.3M | $677K | $311K | $97K | |
| Net Income to Company | -$170K | -$3.4M | -$1.2M | -$4.8M | -$1.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$170K | -$3.4M | -$1.2M | -$4.8M | -$1.2M | |
| Basic EPS (Cont. Ops) | -$0.00 | -$0.08 | -$0.03 | -$0.11 | -$0.03 | |
| Diluted EPS (Cont. Ops) | -- | -$0.08 | -$0.03 | -$0.11 | -$0.03 | |
| Weighted Average Basic Share | $40.8M | $41.6M | $42.7M | $43.6M | $44.6M | |
| Weighted Average Diluted Share | $40.8M | $41.6M | $42.7M | $43.6M | $44.6M | |
| EBITDA | $2.5M | -$489K | $846K | $76K | $1.6M | |
| EBIT | $648K | -$2.4M | -$933K | -$1.7M | $245K | |
| Revenue (Reported) | $29.7M | $26.9M | $25.4M | $22M | $20.6M | |
| Operating Income (Reported) | $648K | -$2.4M | -$933K | -$1.7M | $245K | |
| Operating Income (Adjusted) | $648K | -$2.4M | -$933K | -$1.7M | $245K | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $116.8M | $118M | $112.5M | $97.7M | $87.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $56.9M | $58M | $52.6M | $46M | $42.1M | |
| Gross Profit | $60M | $59.9M | $60M | $51.7M | $45.3M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $10.2M | $12.4M | $11.5M | $11.2M | $9M | |
| Selling, General & Admin | $46.6M | $51.2M | $47.2M | $45M | $37.9M | |
| Other Inc / (Exp) | -$2.7M | -$119K | $197K | -$5.7M | -- | |
| Operating Expenses | $55.3M | $63.1M | $58.3M | $56.2M | $46.9M | |
| Operating Income | $4.6M | -$3.1M | $1.6M | -$4.5M | -$1.6M | |
| Net Interest Expenses | $2.3M | $2M | $3.7M | $3.2M | $3.4M | |
| EBT. Incl. Unusual Items | -$1.8M | -$7.2M | -$2.3M | -$13.4M | -$53.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $45K | -$267K | $918K | $883K | $243K | |
| Net Income to Company | -$1.9M | -$6.9M | -$3.3M | -$14.2M | -$53.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$1.9M | -$6.9M | -$3.3M | -$14.2M | -$53.8M | |
| Basic EPS (Cont. Ops) | -$0.05 | -$0.17 | -$0.08 | -$0.33 | -$1.22 | |
| Diluted EPS (Cont. Ops) | -$0.05 | -$0.17 | -$0.08 | -$0.33 | -$1.22 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $12.2M | $4.4M | $8.8M | $2.5M | $4.7M | |
| EBIT | $4.6M | -$3.1M | $1.6M | -$4.5M | -$1.6M | |
| Revenue (Reported) | $116.8M | $118M | $112.5M | $97.7M | $87.4M | |
| Operating Income (Reported) | $4.6M | -$3.1M | $1.6M | -$4.5M | -$1.6M | |
| Operating Income (Adjusted) | $4.6M | -$3.1M | $1.6M | -$4.5M | -$1.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $85.8M | $84.9M | $84.1M | $69.6M | $62.8M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $39.2M | $43.1M | $38.5M | $32.8M | $30.3M | |
| Gross Profit | $46.6M | $41.8M | $45.6M | $36.8M | $32.6M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $7.8M | $9.5M | $8.6M | $8.1M | $6.6M | |
| Selling, General & Admin | $35.5M | $37.7M | $35.4M | $33.5M | $27.7M | |
| Other Inc / (Exp) | -$477K | $70K | -$268K | -$5.1M | -$49.4M | |
| Operating Expenses | $46.2M | $46.6M | $44M | $41.6M | $34.4M | |
| Operating Income | $467K | -$4.8M | $1.6M | -$4.8M | -$1.8M | |
| Net Interest Expenses | $1.2M | $1.6M | $2.8M | $2.4M | $2.6M | |
| EBT. Incl. Unusual Items | -$1.3M | -$8.3M | -$1.5M | -$12.3M | -$54.2M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$22K | -$437K | $144K | $168K | -$329K | |
| Net Income to Company | -$1.2M | -$7.9M | -$1.6M | -$12.4M | -$53.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$1.2M | -$7.9M | -$1.6M | -$12.4M | -$53.9M | |
| Basic EPS (Cont. Ops) | -$0.03 | -$0.19 | -$0.04 | -$0.29 | -$1.22 | |
| Diluted EPS (Cont. Ops) | -$0.03 | -$0.19 | -$0.04 | -$0.29 | -$1.22 | |
| Weighted Average Basic Share | $120.7M | $124.2M | $127.2M | $130.5M | $133M | |
| Weighted Average Diluted Share | $120.7M | $125.4M | $127.8M | $130.5M | $133M | |
| EBITDA | $5.8M | $786K | $6.8M | $438K | $2.7M | |
| EBIT | $120K | -$4.8M | $1.6M | -$4.8M | -$1.8M | |
| Revenue (Reported) | $85.8M | $84.9M | $84.1M | $69.6M | $62.8M | |
| Operating Income (Reported) | $467K | -$4.8M | $1.6M | -$4.8M | -$1.8M | |
| Operating Income (Adjusted) | $120K | -$4.8M | $1.6M | -$4.8M | -$1.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $8.3M | $7.8M | $4.5M | $4.3M | $4.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $17.8M | $21.8M | $16.7M | $16.1M | $14.9M | |
| Inventory | $22.3M | $27.6M | $26.4M | $24.7M | $23.2M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $3.4M | $4.3M | $3.5M | $3.9M | $2.9M | |
| Total Current Assets | $51.7M | $61.6M | $51.1M | $49M | $45.1M | |
| Property Plant And Equipment | $11.7M | $10.3M | $9.2M | $8.8M | $11.2M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $58.6M | $57.7M | $56.3M | $57.1M | $56.3M | |
| Other Intangibles | $33.2M | $27.4M | $21M | $16M | $11.1M | |
| Other Long-Term Assets | $1.1M | $5.4M | $7.8M | $6.5M | $2.8M | |
| Total Assets | $156.3M | $162.3M | $145.4M | $137.4M | $126.6M | |
| Accounts Payable | $6M | $4.9M | $6.4M | $5.6M | $4.8M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $1.7M | $3.2M | $3.8M | $5.9M | $37M | |
| Current Portion Of Capital Lease Obligations | $2.1M | $2.1M | $2.1M | $1.4M | $1.2M | |
| Other Current Liabilities | $3.3M | $4.3M | $4M | $5.3M | $6.5M | |
| Total Current Liabilities | $21.1M | $25.3M | $23.2M | $26.5M | $55M | |
| Long-Term Debt | $46.3M | $51.6M | $48.3M | $35.5M | $6.4M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $79.6M | $78.9M | $73.1M | $64.3M | $63.3M | |
| Common Stock | $444K | $452K | $454K | $434K | $441K | |
| Other Common Equity Adj | -$13.1M | -$10M | -$15.1M | -$14.2M | -$15.7M | |
| Common Equity | $76.7M | $83.4M | $72.2M | $73.1M | $63.3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $76.7M | $83.4M | $72.2M | $73.1M | $63.3M | |
| Total Liabilities and Equity | $156.3M | $162.3M | $145.4M | $137.4M | $126.6M | |
| Cash and Short Terms | $8.3M | $7.8M | $4.5M | $4.3M | $4.1M | |
| Total Debt | $48M | $54.8M | $52.1M | $41.4M | $43.3M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $5.5M | $5.1M | $5.3M | $4.6M | $6.8M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $18.3M | $15M | $15M | $12.8M | $12.1M | |
| Inventory | $26M | $26.1M | $25.8M | $26M | $21.6M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $5.8M | $5.5M | $4.3M | $3.4M | -- | |
| Total Current Assets | $55.7M | $51.8M | $50.5M | $46.8M | $43.8M | |
| Property Plant And Equipment | $10.5M | $9.6M | $8.4M | $11.7M | $12.5M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $58M | $54.9M | $56.2M | $57.4M | -- | |
| Other Intangibles | $28.9M | $22.5M | $17.1M | $12.3M | -- | |
| Other Long-Term Assets | $724K | $8.3M | $7.5M | $2.9M | -- | |
| Total Assets | $153.9M | $147M | $139.7M | $131.2M | $78M | |
| Accounts Payable | $5.6M | $5.9M | $6.3M | $5.3M | $5.2M | |
| Accrued Expenses | $369K | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $2.5M | $2.7M | $3.5M | $3.6M | -- | |
| Current Portion Of Capital Lease Obligations | $2.1M | $2.1M | $2.1M | $1.1M | -- | |
| Other Current Liabilities | $4.8M | $3.7M | $4.7M | $6.8M | -- | |
| Total Current Liabilities | $23.5M | $21.4M | $24.2M | $22.8M | $54.4M | |
| Long-Term Debt | $49.5M | $52.1M | $39.7M | $41M | $7.3M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $77M | $75M | $65.4M | $65.9M | $63.9M | |
| Common Stock | $451K | $453K | $457K | $436K | $446K | |
| Other Common Equity Adj | -$15M | -$16.2M | -$15.3M | -$13.1M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $76.9M | $72M | $74.3M | $65.3M | $14.1M | |
| Total Liabilities and Equity | $153.9M | $147M | $139.7M | $131.2M | $78M | |
| Cash and Short Terms | $5.5M | $5.1M | $5.3M | $4.6M | $6.8M | |
| Total Debt | $54.1M | $54.8M | $43.2M | $44.6M | $41.3M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$7.8M | -$288K | -$9.5M | -$3.4M | -$12.4M | |
| Depreciation & Amoritzation | $7.6M | $7.6M | $7.6M | $7M | $7.2M | |
| Stock-Based Compensation | $3.6M | $4.2M | $4.4M | $5M | $4.3M | |
| Change in Accounts Receivable | $3.1M | -$4.3M | $4.8M | $810K | $974K | |
| Change in Inventories | $413K | -$5.9M | $252K | $1.5M | -$64K | |
| Cash From Operations | $9.3M | $1.3M | $1.2M | $14M | $1.4M | |
| Capital Expenditures | $1.4M | $1.3M | $1.6M | $2.3M | $3.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.4M | -$1.3M | -$1.6M | -$1.8M | -$1.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $61.3M | $4.3M | $7.8M | $4.5M | $8.8M | |
| Long-Term Debt Repaid | -$66.9M | -$4.2M | -$9.6M | -$15M | -$8.6M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$3M | -$3.6M | -$1.6M | -$2.5M | -$738K | |
| Cash From Financing | -$8M | -$252K | -$2.8M | -$12.1M | -$131K | |
| Beginning Cash (CF) | $8.3M | $7.8M | $4.5M | $4.3M | $4.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$38K | -$496K | -$3.3M | -$225K | -$175K | |
| Ending Cash (CF) | $8.3M | $7.2M | $1.2M | $3.7M | $3.8M | |
| Levered Free Cash Flow | $7.9M | -$83K | -$438K | $11.7M | -$1.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$170K | -$3.4M | -$1.2M | -$4.8M | -$1.2M | |
| Depreciation & Amoritzation | $1.9M | $1.9M | $1.8M | $1.8M | $1.3M | |
| Stock-Based Compensation | $1M | $1.1M | $1.4M | $1.1M | $324K | |
| Change in Accounts Receivable | -$1.1M | $2.5M | $1.8M | -$155K | -$210K | |
| Change in Inventories | -$1.5M | $2.3M | -$225K | -$668K | $637K | |
| Cash From Operations | -$558K | $649K | $4.4M | -$842K | $830K | |
| Capital Expenditures | $480K | $442K | $401K | $1.1M | $348K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$480K | -$442K | -$401K | -$1.1M | -$348K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $2.5M | $2.5M | $1M | $3.3M | -- | |
| Long-Term Debt Repaid | -$500K | -$1.8M | -$3.8M | -$1M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1.7M | -$387K | -- | -$161K | -- | |
| Cash From Financing | $385K | $377K | -$2.8M | $2.1M | -$1M | |
| Beginning Cash (CF) | $5.5M | $5.1M | $5.3M | $4.6M | $6.8M | |
| Foreign Exchange Rate Adjustment | -$36K | $301K | -$194K | $370K | -$83K | |
| Additions / Reductions | -$689K | $885K | $1M | $521K | -$625K | |
| Ending Cash (CF) | $4.8M | $6.3M | $6.2M | $5.5M | $6.1M | |
| Levered Free Cash Flow | -$1M | $207K | $4M | -$2M | $482K | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$1.9M | -$6.9M | -$3.3M | -$14.2M | -$53.8M | |
| Depreciation & Amoritzation | $7.6M | $7.5M | $7.2M | $7.2M | $6.4M | |
| Stock-Based Compensation | $4.1M | $4.4M | $4.6M | $4.8M | $2.4M | |
| Change in Accounts Receivable | -$4.4M | $2.5M | $471K | $2.4M | $693K | |
| Change in Inventories | -$3.1M | -$2.1M | $754K | -$1.1M | $4.6M | |
| Cash From Operations | $3.6M | -$1.4M | $12.4M | $4M | $7.9M | |
| Capital Expenditures | $1.1M | $1.7M | $1.5M | $3.9M | $1.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$1.3M | -$1.7M | -$973K | -$1.9M | -$1.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $54.2M | $9.6M | $3.5M | $9.8M | -- | |
| Long-Term Debt Repaid | -$52.2M | -$5.8M | -$14.3M | -$10.8M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$4.9M | -$2M | -$912K | -$2.3M | -- | |
| Cash From Financing | $511K | $2.5M | -$10.7M | -$2.9M | -$4.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $2.7M | -$404K | $196K | -$771K | $2.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $2.6M | -$3.1M | $10.9M | $160K | $6.1M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$1.2M | -$7.9M | -$1.6M | -$12.4M | -$53.9M | |
| Depreciation & Amoritzation | $5.7M | $5.6M | $5.2M | $5.4M | $4.6M | |
| Stock-Based Compensation | $3.1M | $3.4M | $3.6M | $3.4M | $1.4M | |
| Change in Accounts Receivable | -$727K | $6.1M | $1.8M | $3.3M | $3M | |
| Change in Inventories | -$4M | -$329K | $173K | -$2.4M | $2.3M | |
| Cash From Operations | $1.2M | -$1.5M | $9.7M | -$285K | $6.1M | |
| Capital Expenditures | $987K | $1.4M | $1.3M | $2.8M | $1.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$987K | -$1.4M | -$738K | -$878K | -$1.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $2.5M | $7.8M | $3.5M | $8.8M | -- | |
| Long-Term Debt Repaid | -$5.5M | -$7.1M | -$11.8M | -$7.6M | -$2M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$2.8M | -$1.2M | -$451K | -$220K | -$508K | |
| Cash From Financing | -$2.9M | -$107K | -$8M | $1.2M | -$3.1M | |
| Beginning Cash (CF) | $19.7M | $14.8M | $13.5M | $12.9M | $19.8M | |
| Foreign Exchange Rate Adjustment | -$81K | $312K | -$137K | $223K | $888K | |
| Additions / Reductions | -$2.7M | -$2.7M | $832K | $286K | $2.7M | |
| Ending Cash (CF) | $16.9M | $12.5M | $14.1M | $13.4M | $23.4M | |
| Levered Free Cash Flow | $260K | -$2.9M | $8.5M | -$3.1M | $4.9M | |
Get HBIO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HBIO
Sector
P/E ratio
--
23.89x
PEG ratio
0.00x
-0.01x
P/B ratio
2.30x
1.82x
Price / LTM sales
0.37x
1.60x
Growth Metrics
HBIO
Sector
Revenue growth
-6.28%
4.62%
Earnings growth
74.93%
10.88%
Revenue (5-year growth)
-4.12%
6.5%
Earnings forecast
$0.01
-$0.21
Profitability
HBIO
Sector
Profitability FY 2024
$49.6M
$3.5M
Return on invested capital
-68.29%
-31.77%
Return on assets
-54.29%
-27.96%
Return on equity
-155.33%
-37.63%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Mar
12
Estimated Next Earnings Date
Feb
5
Balance Sheet
HBIO
Sector
Total cash
$6.8M
$26.3M
Short term investments
--
$25.7M
Total assets
$126.6M
$78M
Long term debt
$41.3M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
